Home › Pulmonary Arterial Hypertension › Washington
Pulmonary Arterial Hypertension clinical trials in Washington
5 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Washington.
Cities in Washington
Repurposing Valsartan May Protect Against Pulmonary Hypertension
- University of Washington Medical Center, Seattle
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated May 4, 2026 · NCT06053580Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- Seattle Children's Hospital ( Site 1605), Seattle
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated Apr 20, 2026 · NCT05587712Pulmonary Hypertension Association Registry
- Seattle Children's Hospital, Seattle
- University of Washington, Seattle
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327PAH Exercise Study
- University of Washington, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 23, 2025 · NCT06941441Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Seattle Children's Hospital, Seattle
RecruitingObservational study
1 Day – 21 Years · All sexes · Updated Mar 13, 2025 · NCT02249923From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.